Resverlogix (RVX) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free RVX Stock Alerts C$0.06 0.00 (0.00%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineResverlogix Announces Change to Its Board of Directorsfinance.yahoo.com - February 21 at 8:02 PMResverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalone's Potential Therapeutic Benefitsfinance.yahoo.com - January 11 at 10:03 AMClosing Bell: Resverlogix Corp flat on Tuesday (RVX)theglobeandmail.com - January 4 at 6:16 PMResverlogix Corp. (RVX) Earnings Dates & Reportsinvesting.com - December 19 at 7:28 PMResverlogix Corp RVXCFmorningstar.com - November 18 at 5:49 PMResverlogix Corp RVXmorningstar.com - November 1 at 11:18 AMResverlogix: Top 10 Undervalued Healthcare Sector Stocks on TSX (RVX)theglobeandmail.com - October 18 at 7:46 AMResverlogix Corp.: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophyfinanznachrichten.de - October 4 at 10:11 AMResverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophyfinance.yahoo.com - October 4 at 10:11 AMAtherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsightfinance.yahoo.com - September 26 at 8:50 PMResverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetesfinance.yahoo.com - August 29 at 10:13 AMClosing Bell: Resverlogix Corp up on Wednesday (RVX)theglobeandmail.com - August 24 at 3:35 PMClosing Bell: Resverlogix Corp flat on Monday (RVX)theglobeandmail.com - August 14 at 10:02 PMClosing Bell: Resverlogix Corp Warrants down on Wednesday (RVX-WT-A)theglobeandmail.com - July 12 at 7:21 AMResverlogix Announces Warrant Repricing and One-Year Extensionfinance.yahoo.com - June 29 at 11:09 PMResverlogix Corp.: Resverlogix Announces Voting Results from the 2023 Meeting of Shareholdersfinanznachrichten.de - June 20 at 7:31 PMResverlogix Announces Voting Results from the 2023 Meeting of Shareholdersfinance.yahoo.com - June 20 at 7:31 PMResverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patientsfinance.yahoo.com - June 12 at 6:42 PMCanadian Investment Regulatory Organization Trading Halt - RVX.WT.Afinance.yahoo.com - June 7 at 1:32 PMClosing Bell: Resverlogix Corp Warrants down on Friday (RVX-WT-A)theglobeandmail.com - June 6 at 10:49 AMClosing Bell: Resverlogix Corp Warrants down on Tuesday (RVX-WT-A)theglobeandmail.com - May 25 at 12:52 AMCBOE RUSSELL 2000 VOLATILITY IN (^RVX)finance.yahoo.com - May 18 at 12:38 AMClosing Bell: Resverlogix Corp down on Monday (RVX)theglobeandmail.com - May 2 at 9:45 AMClosing Bell: Resverlogix Corp flat on Friday (RVX)theglobeandmail.com - April 29 at 1:16 AMClosing Bell: Resverlogix Corp Warrants flat on Thursday (RVX-WT-A)theglobeandmail.com - April 28 at 8:10 PMClosing Bell: Resverlogix Corp up on Thursday (RVX)theglobeandmail.com - April 27 at 11:21 PMClosing Bell: Resverlogix Corp down on Wednesday (RVX)theglobeandmail.com - April 27 at 3:19 AMClosing Bell: Resverlogix Corp down on Tuesday (RVX)theglobeandmail.com - April 25 at 11:02 PMClosing Bell: Resverlogix Corp down on Friday (RVX)theglobeandmail.com - April 22 at 8:09 PMClosing Bell: Resverlogix Corp Warrants flat on Friday (RVX-WT-A)theglobeandmail.com - April 18 at 7:47 PMClosing Bell: Resverlogix Corp up on Friday (RVX)theglobeandmail.com - April 15 at 3:18 PMClosing Bell: Resverlogix Corp Warrants flat on Wednesday (RVX-WT-A)theglobeandmail.com - April 13 at 10:43 PMClosing Bell: Resverlogix Corp Warrants flat on Wednesday (RVX-WT-A)theglobeandmail.com - April 13 at 10:43 PMClosing Bell: Resverlogix Corp Warrants flat on Tuesday (RVX-WT-A)theglobeandmail.com - April 13 at 2:40 AMClosing Bell: Resverlogix Corp Warrants flat on Monday (RVX-WT-A)theglobeandmail.com - April 12 at 6:38 AMClosing Bell: Resverlogix Corp down on Thursday (RVX)theglobeandmail.com - April 8 at 7:27 AMResverlogix extends debenture maturity by one yearmsn.com - March 20 at 2:21 PMResverlogix Announces New Research Highlighting Apabetalone's Potential Benefits in Cardiovascular Disease, Heart Failure, and COVID-19finance.yahoo.com - March 2 at 12:10 PMInsiders who bought in the last 12 months lose an additional US$43k as Resverlogix Corp. (TSE:RVX) drops to CA$44mfinance.yahoo.com - December 11 at 6:20 PMInvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone's Future Development for the Prevention and Treatment of Post COVID-19 Conditions - GlobeNewswireglobenewswire.com - September 30 at 9:25 AMInvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone’s Future Development for the Prevention and Treatment of Post COVID-19 Conditionsfinance.yahoo.com - September 30 at 9:25 AMResverlogix Confirms Focus on Treatment of Post COVID-19 Conditions - GlobeNewswireglobenewswire.com - September 28 at 10:04 AMResverlogix Confirms Focus on Treatment of Post COVID-19 Conditionsfinance.yahoo.com - September 28 at 10:04 AMRVX.TO - Resverlogix Corp. | Stock Price & Latest News | Reutersreuters.com - September 15 at 11:23 AMResverlogix Publishes New Data Highlighting Apabetalone's - GlobeNewswireglobenewswire.com - August 22 at 8:31 AMResverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Diseasefinance.yahoo.com - August 22 at 8:31 AMResverlogix Announces Appointment of New Chief Scientific Officer - GlobeNewswireglobenewswire.com - August 16 at 8:44 AMResverlogix Announces Appointment of New Chief Scientific Officerfinance.yahoo.com - August 15 at 6:59 PMResverlogix Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 - Marketscreener.commarketscreener.com - August 13 at 12:59 PMPulmonary Hypertension Clinical Trials Pipeline Offers Promising Novel Treatment Options | DelveInsight - GlobeNewswireglobenewswire.com - August 1 at 1:20 PM Get Resverlogix News Delivered to You Automatically Sign up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Gold Set to EXPLODE! (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! RVX Media Mentions By Week RVX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RVX News Sentiment▼0.000.58▲Average Medical News Sentiment RVX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RVX Articles This Week▼00▲RVX Articles Average Week Get Resverlogix News Delivered to You Automatically Sign up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sirona Biochem News Today Kane Biotech News Today Antibe Therapeutics News Today Ceapro News Today Aeterna Zentaris News Today Aptose Biosciences News Today Quest PharmaTech News Today Covalon Technologies News Today IBEX Technologies News Today Microbix Biosystems News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:RVX) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsCollapse of the Petrodollar Colonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe Exchange[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Resverlogix Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.